Oncolytic Virus Therapy Market Size, Share, Industry, Forecast and outlook (2024-2031)
Published: 2024 January 05
SKU : PH100
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What is the Projected CAGR value of the Oncolytic Virus Therapy Market?
The Projected CAGR value is 19.32%.
Who are the key players in Oncolytic Virus Therapy Market?
Key players are Amgen, Shanghai Sunway Biotech Co. Ltd, and RIGVIR.
Related Reports
pharmaceuticalsPenile Cancer Treatment Market Size, Share, Forecast and Outlook (2023-2030)
Published: 2023 September 26
Starting from
$4350
pharmaceuticalsLiposarcoma Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 September 26
Starting from
$4350
pharmaceuticalsRetinoblastoma Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 November 02
Starting from
$4350
pharmaceuticalsMetastatic Colorectal Cancer Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 October 05
Starting from
$4350
pharmaceuticalsAdenoid Cystic Carcinoma Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Published: 2023 September 21
Starting from
$4350
pharmaceuticalsHepatoblastoma Market Size, Share, Industry, Forecast and Outlook (2024-2031)
Published: 2024 March 06
Starting from
$4350